WHO ICTRP trial
Child outcomes after prenatal progesterone for prevention of preterm birth…
NL-OMON27515 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON27515 |
|---|---|
| Public title | Child outcomes after prenatal progesterone for prevention of preterm birth, follow-up of the AMPHIA trial |
| Scientific title | Long-term follow-up of children exposed in-utero to progesterone for prevention of preterm birth: follow-up of the AMPHIA trial |
| Primary sponsor | Amsterdam UMC - location AMC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational non invasive |
| Conditions | Prevention of preterm birth in multiple pregnancy |
| Interventions | Progesterone |
| Registration date | Sep 29, 2020 |
| Target size | 300 |
| Secondary IDs | NL8933;METC AMC : W20_234 # 20.268 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: